The Insertion of I-gel and Classic LMA in Different Head Positions in Elderly Patients

NCT ID: NCT07027293

Last Updated: 2025-09-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-20

Study Completion Date

2025-09-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This prospective, randomized, double-blind clinical study aims to evaluate the insertion success of two supraglottic airway devices, the classic Laryngeal Mask Airway (LMA) and the I-gel, in different head and neck positions in elderly patients undergoing elective urological surgery under general anesthesia. A total of 120 patients aged over 75 years with ASA physical status I-III will be randomly assigned to one of four groups: standard position with I-gel, right lateral rotation with I-gel, standard position with classic LMA, and right lateral rotation with classic LMA. The study will compare insertion time, ease and success of placement, number of attempts, hemodynamic responses, oropharyngeal leak pressures, fiberoptic scores, and airway-related complications. The findings aim to provide clinical guidance on the optimal use of supraglottic airway devices in geriatric patients in various head positions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Airway Management Assessment Supraglottic Airways Supraglottic Airways for General Anesthesia Laryngeal Mask Airways

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard head position + i-gel

Group Type ACTIVE_COMPARATOR

STANDART HEAD POSITION

Intervention Type OTHER

STANDART HEAD POSITION

i-gel supraglottic airway device

Intervention Type DEVICE

i-gel supraglottic airway device

Rotated head position + i-gel

Group Type ACTIVE_COMPARATOR

HEAD ROTATION POSITION

Intervention Type OTHER

HEAD ROTATION POSITION

i-gel supraglottic airway device

Intervention Type DEVICE

i-gel supraglottic airway device

Standard head position + classic LMA

Group Type ACTIVE_COMPARATOR

STANDART HEAD POSITION

Intervention Type OTHER

STANDART HEAD POSITION

Classic laryngeal mask airway (LMA)

Intervention Type DEVICE

Classic laryngeal mask airway (LMA)

Rotated head position + classic LMA

Group Type ACTIVE_COMPARATOR

HEAD ROTATION POSITION

Intervention Type OTHER

HEAD ROTATION POSITION

Classic laryngeal mask airway (LMA)

Intervention Type DEVICE

Classic laryngeal mask airway (LMA)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

STANDART HEAD POSITION

STANDART HEAD POSITION

Intervention Type OTHER

HEAD ROTATION POSITION

HEAD ROTATION POSITION

Intervention Type OTHER

Classic laryngeal mask airway (LMA)

Classic laryngeal mask airway (LMA)

Intervention Type DEVICE

i-gel supraglottic airway device

i-gel supraglottic airway device

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ASA classification I-III
* Age over 75 years

Exclusion Criteria

* Known or anticipated difficult airway
* Contraindications for the use of a supraglottic airway device
* Patients scheduled for endotracheal intubation
Minimum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yadigar Yılmaz

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Yadigar Yılmaz

Istanbul, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yadigar Yılmaz

Role: primary

5053069924

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

E-10840098-202.3.02-1265

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.